Factors Associated with RANTES Concentration in Cardiovascular Disease Patients

Table 1

Clinical characteristics of AMI subjects depending on the severity of signs and symptoms (STEMI, NSTEMI) as compared to SA individuals. Results are presented as median and interquartiles.

	AMI; N=83	STEMI; N=38	NSTEMI; N=45	SA; N=32	AMI vs. SA; STEMI vs. SA; NSTEMI vs. SA	STEMI; vs. NSTEMI
Systolic BP [mmHg]	140 (126-151)	140 (126-150)	136 (126-153)	129 (100-145)	NS; NS; NS	NS
Diastolic BP [mmHg]	85 (77-92)	88 (80-96)	80 (75-90)	76 (55-90)	NS; NS; NS	NS
Ejection fraction [%]	45 (40-55)	45 (43-50)	48 (38-60)	55 (28-60)	NS; NS; NS	NS
Heart rate/minute	75 (66-88)	80 (70-90)	74 (65-87)	90 (68-150)	NS; NS; NS	NS
Medications on admission
Aspirin N (%)	78 (94%)	37 (97%)	41 (91%)	4 (13%)	<0.001; <0.001; <0.001	NS
Clopidogrel N (%)	64 (77%)	29 (76%)	35 (78%)	1 (3%)	<0.001; <0.001; <0.001	NS
Heparin N (%)	13 (16%)	4 (11%)	9 (20%)	-	0.017; NS; 0.027	NS
Coronary risk factors
Hypertension N (%)	58 (70%)	29 (76%)	29 (64%)	20 (63%)	NS; NS; NS	NS
Diabetes t.2 N (%)	25 (30%)	14 (37%)	11 (24%)	12 (38%)	NS; NS; NS	NS
Hyperlipidemia N (%)	53 (64%)	25 (66%)	28 (62%)	15 (47%)	NS; NS; NS	NS
Obesity N (%)	22 (27%)	13 (34%)	9 (20%)	3 (9%)	0.045; 0.013; NS	NS
Smoking N (%)	21 (25%)	10 (26%)	11 (24%)	1 (3%)	0.006; 0.007; 0.011	NS

AMI: acute myocardial infarction, BP: blood pressure, N: number of individuals, NS: not statistically significant, NSTEMI: non-ST elevation myocardial infarction, SA: stable angina, STEMI: ST elevation myocardial infarction.